Tag-Archive for ◊ medical device market ◊

• Tuesday, February 04th, 2014

Bard Announces $500 Million Share Repurchase Authorization MURRAY HILL, N.J.–(BUSINESS WIRE)–C. R. Bard, Inc. (NYSE:BCR) today announced that its Board of Directors has authorized the repurchase of up to $500 million of the company’s common stock. This new authorization is in addition to the approximately $55 million remaining under the Company’s prior authorization. Share repurchases […]

• Friday, November 29th, 2013

COLUMBIA — More than $1 million of tax credits have been granted to a biotech start-up in Columbia. Nanova Biomaterials Inc., a biotechnology company still in its early stage, plans to expand to a new building in north Columbia, purchase new equipments and make renovations, company President Han Li said. The company received $7 million […]

• Friday, November 22nd, 2013

Hologic Inc. (HOLX), a maker of cervical cancer and breast biopsy tools, adopted a shareholder’s rights plan after billionaire investor Carl Icahn reported a 13 percent stake in the company and said he may seek board seats. The rights plan is designed to make sure all shareholders are “appropriately compensated” and the board has time to make […]

• Thursday, November 21st, 2013

Minnesota medical device maker Cardiovascular Systems plans to offer more than 2.1 million shares of its common stock, a potential take of $70 million based on the company’s estimates. Cardiovascular Systems (NSDQ:CSII) announced this week an upcoming stock offering worth up to $70 million in net proceeds, according to an early estimate. The device maker has yet […]

• Friday, November 15th, 2013

Cook Medical promotes Pete Yonkman to president of the Cook Group’s medical subsidiaries, with Hawking remaining president of Cook Group. Cook Medical said it named Pete Yonkman as president, with Kem Hawkins stepping down from the role to better oversee Cook Group altogether. Yonkman has been with Cook Medical for the past 12 years, originally […]

• Thursday, November 14th, 2013

ConMed responds to a challenge from activist investor group Voce Capital Management, citing “the strong operating performance delivered by ConMed over the past several years.” ConMed (NSDQ:CNMD) today responded to a long and critical letter from Voce Capital Management issued last week that demanded steps toward a strategic exit and the end “a culture of nepotism, […]

• Wednesday, November 13th, 2013

IRVINE, CA–(Marketwired – November 11, 2013) – BIOLASE, Inc. (NASDAQ: BIOL), the world’s leading manufacturer and distributor of dental lasers, and a pioneer in laser surgery in other medical specialties, today announced that its Board of Directors (“Board”) has authorized BIOLASE to seek the services of an investment bank to explore possible M&A transactions with the […]

• Saturday, October 19th, 2013

(Reuters) – Medical products maker Baxter International Inc reported a 7 percent fall in third-quarter earnings, hurt by charges related to its $4 billion acquisition of Swedish dialysis products company Gambro AB. Net earnings fell to $544 million, or 99 cents per share, from $583 million, or $1.06 per share, a year earlier. Excluding special items, […]

• Monday, October 14th, 2013

LDR Prices Initial Public Offering AUSTIN, Texas, Oct 08, 2013 (Menafn – GLOBE NEWSWIRE via COMTEX) –LDR Holding Corporation LDRH (“LDR” or the “Company”), a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, today announced the pricing of its initial public offering of 5,000,000 shares of common stock […]

• Thursday, September 05th, 2013

A group of Biolase shareholders are suing in a class action lawsuit accusing company directors of lying about its financial struggles. Biolase (NSDQ:BLTI) is facing a lawsuit brought by shareholders accusing the company of hiding problems by lying on quarterly earnings reports. The lawsuit claims Biolase and its directors concealed liquidity and solvency issues as well […]